Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Radamin Viro
- Development stage
- Phase 3
- Lead developer
- Promomed
- Modality
- RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
Radamin Viro is a prescription biologic drug developed and manufactured by Promomed Group. Its active ingredient is RNA double-stranded sodium salt, which functions as a unique immunostimulatory agent. The drug's mechanism of action involves increasing the production of endogenous interferons, thereby enhancing cellular immunity and rapidly activating both innate and acquired immune responses. Radamin Viro is indicated for the prevention and treatment of various viral and infectious-inflammatory diseases, including influenza, acute respiratory viral infections (such as COVID-19), herpes virus infections, and chlamydia infections. It is administered via intramuscular and subcutaneous routes.
- Brand names
- Radamin Viro
- Other names
- RNA double-stranded sodium salt
02
Targets
Pattern recognition receptor sensing double-stranded RNA (dsRNA-sensing PRR)
Beyond the preview
Go deeper on Radamin Viro.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Radamin Viro.